Active Pharmaceutical Ingredient (API) Market Size, Analysis and Forecast 2031

The Active Pharmaceutical Ingredient (API) Market in 2023 is US$ 228.50 billion, and is expected to reach US$ around 379 billion by 2031 at a CAGR of 6.60%.

FutureWise Research published a report that analyzes Active Pharmaceutical Ingredient (API) Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Active Pharmaceutical Ingredient (API) research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

Request a Sample Report @ Request for Active Pharmaceutical Ingredient (API) Market Sample

Active Pharmaceutical Ingredient (API) Market Segmentation:

By Drug Type

· Prescription Drugs

· Over-the-counter Drugs

By Manufacturer

· Captive (In-House) Manufacturer

· Merchant (Contract) Manufacturer

By Therapeutic Application

· Communicable Diseases

· Oncology

· Diabetes

· Cardiovascular Disease

· Pain management

· Respiratory Diseases

· Other Therapeutic Applications

By Synthesis

· Synthetic

· Type

· Innovative Synthetic API

· Generic Synthetic API

· Biotech

· Type

· Innovative Synthetic API

· Generic Synthetic API

· Product

· Monoclonal Antibodies

· Hormones

· Cytokines

· Recombinant Proteins

· Therapeutic Enzymes

· Vaccines

· Blood Factors

· Expression System

· Mammalian Expression Systems

· Microbial Expression Systems

· Yeast Expression Systems

· Insect Expression Systems

· Other Expression Systems

By End-Use

· Pharmaceutical And Biotechnology Industry

· Contract Research Organizations

· Contract Manufacturing Organizations

· Other End-User

By Region

· North America

· Europe

· Asia- Pacific

· Latin America

· Middle East and Africa

Major players included in the Active Pharmaceutical Ingredient (API) Market:

· Pfizer Inc.

· Novartis International AG

· Sanofi

· Boehringer Ingelheim

· Bristol-Myers Squibb

· Teva Pharmaceutical Industries Ltd.

· Eli Lilly and Company

· GlaxoSmithKline plc

· Merck & Co., Inc.

· AbbVie Inc.

· F. Hoffmann-La Roche Ltd.

· AstraZeneca

· Cipla, Inc.

· Mylan N.V.

· Dr. Reddy’s Laboratories Ltd

· Sun Pharmaceutical Industries Ltd.

· API Pharma Tech

· BDR Pharmaceuticals Internationals Pvt. Ltd.

· Sreepathi Pharmaceuticals Limited

· Shilpa Medicare Limited

· Albemarle Corporation

· Viatris Inc.

· Aurobindo Pharma

Active Pharmaceutical Ingredient (API) Market Size, Analysis and Forecast 2031

Language